Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
7
pubmed:dateCreated
2008-11-25
pubmed:abstractText
The endocannabinoid virodhamine is a partial agonist at the cannabinoid CB(1) receptor and a full agonist at the CB(2) receptor, and relaxes rat mesenteric arteries through endothelial cannabinoid receptors. Its concentration in the periphery exceeds that of the endocannabinoid anandamide. Here, we examined the influence of virodhamine on the human pulmonary artery.
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/18806815-10193775, http://linkedlifedata.com/resource/pubmed/commentcorrection/18806815-11412008, http://linkedlifedata.com/resource/pubmed/commentcorrection/18806815-11682448, http://linkedlifedata.com/resource/pubmed/commentcorrection/18806815-12023533, http://linkedlifedata.com/resource/pubmed/commentcorrection/18806815-12163339, http://linkedlifedata.com/resource/pubmed/commentcorrection/18806815-12412837, http://linkedlifedata.com/resource/pubmed/commentcorrection/18806815-12606780, http://linkedlifedata.com/resource/pubmed/commentcorrection/18806815-12711633, http://linkedlifedata.com/resource/pubmed/commentcorrection/18806815-14645143, http://linkedlifedata.com/resource/pubmed/commentcorrection/18806815-14744801, http://linkedlifedata.com/resource/pubmed/commentcorrection/18806815-15131000, http://linkedlifedata.com/resource/pubmed/commentcorrection/18806815-15148250, http://linkedlifedata.com/resource/pubmed/commentcorrection/18806815-15233865, http://linkedlifedata.com/resource/pubmed/commentcorrection/18806815-15482346, http://linkedlifedata.com/resource/pubmed/commentcorrection/18806815-15866316, http://linkedlifedata.com/resource/pubmed/commentcorrection/18806815-15923084, http://linkedlifedata.com/resource/pubmed/commentcorrection/18806815-15997233, http://linkedlifedata.com/resource/pubmed/commentcorrection/18806815-16402104, http://linkedlifedata.com/resource/pubmed/commentcorrection/18806815-16968947, http://linkedlifedata.com/resource/pubmed/commentcorrection/18806815-17245358, http://linkedlifedata.com/resource/pubmed/commentcorrection/18806815-17245363, http://linkedlifedata.com/resource/pubmed/commentcorrection/18806815-17704827, http://linkedlifedata.com/resource/pubmed/commentcorrection/18806815-17876300, http://linkedlifedata.com/resource/pubmed/commentcorrection/18806815-17876302, http://linkedlifedata.com/resource/pubmed/commentcorrection/18806815-17921818, http://linkedlifedata.com/resource/pubmed/commentcorrection/18806815-17927481, http://linkedlifedata.com/resource/pubmed/commentcorrection/18806815-17965195, http://linkedlifedata.com/resource/pubmed/commentcorrection/18806815-9458889, http://linkedlifedata.com/resource/pubmed/commentcorrection/18806815-9931142
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Dec
pubmed:issn
1476-5381
pubmed:author
pubmed:issnType
Electronic
pubmed:volume
155
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1034-42
pubmed:dateRevised
2010-9-21
pubmed:meshHeading
pubmed:year
2008
pubmed:articleTitle
Virodhamine relaxes the human pulmonary artery through the endothelial cannabinoid receptor and indirectly through a COX product.
pubmed:affiliation
Department of Experimental Physiology, Medical University of Bia?ystok, Bia?ystok, Poland. hkozl@umwb.edu.pl
pubmed:publicationType
Journal Article, In Vitro, Research Support, Non-U.S. Gov't